Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dHAM for Postprostatectomy Incontinence and Potency
NCT03864939Phase 3Unknown
- Sponsor
- German Centre for Assessment and Evaluation of Innovative Techniques in Medicine
- Start
- Apr 2019
- Primary completion
- Apr 2024
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dehydrated human amnion membrane in urinary incontinence (UI) and erectile dysfunction (ED) (2 arms), sponsored by German Centre for Assessment and Evaluation of Innovative Techniques in Medicine. Primary endpoint: Change in urine loss at 12 months. Status: unknown.
02
Drugs
dehydrated human amnion membrane
03
Conditions
urinary incontinence (UI)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03864939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03864939.